Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line
1999

Effects of Anthracycline Analogues on Drug Resistance in Leukaemia Cells

publication Evidence: moderate

Author Information

Author(s): Hu X F, Slater A, Rischin D, Kantharidis P, Parkin J D, Zalcberg J

Primary Institution: Peter MacCallum Cancer Institute, Melbourne, Australia

Hypothesis

Can anthracycline analogues induce MDR1 gene expression in drug-resistant leukaemia cells?

Conclusion

Anthracycline analogues can induce stable MDR1 expression in drug-resistant leukaemia cells.

Supporting Evidence

  • IDA and MX2 were found to be significantly more effective than epirubicin in the CEM/A7R cell line.
  • MDR1 expression was induced by IDA and MX2 within 4 hours of exposure.
  • 5-FU only induced MDR1 expression after 24 hours of exposure.

Takeaway

This study found that certain cancer drugs can make resistant cancer cells express a gene that helps them resist treatment, and this change can last even after the drugs are stopped.

Methodology

The study compared the effects of different anthracycline analogues on MDR1 gene expression in a specific leukaemia cell line using cell growth inhibition assays and Northern blotting.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6990133

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication